![Heiko von der Leyen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heiko von der Leyen
Directeur Technique/Scientifique/R&D chez
ORGENESIS INC.
Profil
Mr. Heiko von der Leyen is a Medical Director at Orgenesis, Inc. Mr. von der Leyen was previously employed as a Managing Director by Hannover Clinical Trial Center GmbH, a Chief Scientific Officer by Avontec GmbH, a Chief Scientific Officer by Artiss GmbH, and a Medical Director & VP-Clinical Development by Cardion AG.
Postes actifs de Heiko von der Leyen
| Sociétés | Poste | Début |
|---|---|---|
| ORGENESIS INC. | Directeur Technique/Scientifique/R&D | 01/09/2020 |
Anciens postes connus de Heiko von der Leyen
| Sociétés | Poste | Fin |
|---|---|---|
Hannover Clinical Trial Center GmbH | Corporate Officer/Principal | 01/01/2017 |
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Artiss GmbH | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Directeur Technique/Scientifique/R&D | 01/01/2001 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Orgenesis, Inc.
 Orgenesis, Inc. Packaged SoftwareTechnology Services Offers POCare services platform for biotech companies and hospitals to supply their products and develops potential of cell and gene therapies | Technology Services |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Health Technology |
Avontec GmbH
Avontec GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutic treatments for inflammatory disease | Health Technology |
Hannover Clinical Trial Center GmbH | |
Artiss GmbH |
Choisissez Zonebourse 
